Effects of CD133 Silencing on Survival and Migration of HT-29 Colorectal Cancer Cells.

CONCLUSION: siRNA mediated targeting of CD133 could be considered as a promising approach to treat CRC through suppressing the cancerous behavior of tumor cells. PMID: 31552833 [PubMed - in process]
Source: Iranian Journal of Immunology - Category: Allergy & Immunology Tags: Iran J Immunol Source Type: research